. april 2010 (17) .gelfand noted the impact on hdl may be balanced by the improvement seen in markers of . 10m . .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. .of all car-t cell trials registered since 2001, more than half are being conducted in china.